SENNA 8.6MG

SENNA 8.6MG was reported 54 times

SENNA 8.6MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERIPANCREATIC FLUID COLLECTION 1 0.0066
1 PANCREATIC CARCINOMA RECURRENT 1 0.0041
2 POST PROCEDURAL BILE LEAK 1 0.0032
3 PSEUDOCYST 1 0.0031
4 TONGUE PRURITUS 1 0.0012
5 ABDOMINAL SEPSIS 1 0.0011
6 HEART TRANSPLANT 1 0.0011
7 MOANING 1 0.0009
8 HYPORESPONSIVE TO STIMULI 1 0.0009
9 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
10 TONIC CONVULSION 1 0.0007
11 PANCREATITIS NECROTISING 1 0.0004
12 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
13 METABOLIC ENCEPHALOPATHY 1 0.0003
14 OEDEMA MOUTH 1 0.0003
15 LIVER TRANSPLANT 1 0.0003
16 TONGUE OEDEMA 1 0.0003
17 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
18 LIP OEDEMA 1 0.0002
19 OCULAR ICTERUS 1 0.0002
20 LUMBAR VERTEBRAL FRACTURE 1 0.0002
21 AUTOIMMUNE HEPATITIS 1 0.0001
22 MYASTHENIA GRAVIS 1 0.0001
23 POST PROCEDURAL INFECTION 1 0.0001
24 IRON DEFICIENCY ANAEMIA 1 0.0001
25 LEUKAEMIA 1 0.0001
26 RECALLED PRODUCT ADMINISTERED 1 0.0001
27 HOSPICE CARE 1 0.0001
28 INABILITY TO AFFORD MEDICATION 1 0.0001
29 BRAIN INJURY 1 0.0001
30 PULMONARY THROMBOSIS 1 0.0001
31 PANCREATITIS ACUTE 2 0.0001
32 STATUS EPILEPTICUS 1 0.0001
33 SPINAL PAIN 1 0.0001
34 DIALYSIS 1 0.0001
35 COLON CANCER 1 0.0001
36 INSURANCE ISSUE 1 0.0001
37 CYANOSIS 1 0.0001
38 PRODUCT USE COMPLAINT 1 0.0001
39 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
40 MUSCULOSKELETAL DISCOMFORT 1 0.0001
41 NEUROTOXICITY 1 0.0001
42 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
43 GOUT 1 0.0001
44 RESTLESS LEGS SYNDROME 1 0.0001
45 POST PROCEDURAL COMPLICATION 1 0.0001
46 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
47 PREGNANCY 1 0.0000
48 INTENTIONAL SELF-INJURY 1 0.0000
49 RIB FRACTURE 1 0.0000
50 PERITONITIS 1 0.0000
51 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
52 RASH MACULO-PAPULAR 1 0.0000
53 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
54 DIABETIC KETOACIDOSIS 1 0.0000
55 LOCALISED INFECTION 1 0.0000
56 ENCEPHALOPATHY 1 0.0000
57 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
58 DIPLOPIA 1 0.0000
59 JAUNDICE 1 0.0000
60 BLOOD BILIRUBIN INCREASED 1 0.0000
61 PNEUMONITIS 1 0.0000
62 CARDIAC ARREST 3 0.0000
63 RESPIRATORY DISTRESS 1 0.0000
64 MENTAL STATUS CHANGES 1 0.0000
65 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
66 LIP SWELLING 1 0.0000
67 HAEMATURIA 1 0.0000
68 RASH MACULAR 1 0.0000
69 THERAPY INTERRUPTED 2 0.0000
70 PLASMA CELL MYELOMA 1 0.0000
71 ABORTION SPONTANEOUS 1 0.0000
72 LUNG NEOPLASM MALIGNANT 1 0.0000
73 RHABDOMYOLYSIS 1 0.0000
74 SEPTIC SHOCK 1 0.0000
75 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
76 SYNCOPE 2 0.0000
77 FLUID RETENTION 1 0.0000
78 THERAPY CESSATION 1 0.0000
79 SPEECH DISORDER 1 0.0000
80 DRUG INTERACTION 3 0.0000
81 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
82 ANAPHYLACTIC REACTION 1 0.0000
83 NECK PAIN 1 0.0000
84 OXYGEN SATURATION DECREASED 1 0.0000
85 URINARY TRACT INFECTION 3 0.0000
86 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
87 DYSPHONIA 1 0.0000
88 DISEASE PROGRESSION 2 0.0000
89 SUICIDE ATTEMPT 1 0.0000
90 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
91 EXPOSURE DURING PREGNANCY 1 0.0000
92 NEOPLASM MALIGNANT 1 0.0000
93 CONSTIPATION 3 0.0000
94 RESPIRATORY FAILURE 1 0.0000
95 AGITATION 1 0.0000
96 ACUTE KIDNEY INJURY 2 0.0000
97 HOSPITALISATION 2 0.0000
98 THROMBOSIS 1 0.0000
99 DRY MOUTH 1 0.0000
100 TREATMENT FAILURE 1 0.0000
101 HYPERSENSITIVITY 2 0.0000
102 DYSPHAGIA 1 0.0000
103 GAIT DISTURBANCE 2 0.0000
104 HAEMORRHAGE 1 0.0000
105 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
106 PALPITATIONS 1 0.0000
107 OEDEMA PERIPHERAL 1 0.0000
108 DEATH 7 0.0000
109 HYPERHIDROSIS 1 0.0000
110 MALAISE 3 0.0000
111 TREMOR 1 0.0000
112 COVID-19 1 0.0000
113 PRODUCT USE ISSUE 1 0.0000
114 ASTHENIA 2 0.0000
115 ABDOMINAL PAIN UPPER 1 0.0000
116 DECREASED APPETITE 1 0.0000
117 ABDOMINAL PAIN 1 0.0000
118 FEELING ABNORMAL 1 0.0000
119 COUGH 1 0.0000
120 PRURITUS 1 0.0000
121 FATIGUE 2 0.0000
122 OFF LABEL USE 2 0.0000
123 VOMITING 1 0.0000
124 DIZZINESS 1 0.0000
125 DYSPNOEA 1 0.0000
126 DIARRHOEA 1 0.0000
127 NAUSEA 1 0.0000